Operose Advisors’s Pfizer PFE Stock Holding History

Operose Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$612K	Sell	25,400 -12	-0%	-$314	0.12%	88
2026 Q1	$714K	Buy	25,412 +25,140	+9,243%	+$669K	0.17%	70
2025 Q4	$6.77K	Hold	272	–	–	﹤0.01%	400
2025 Q3	$6.93K	Hold	272	–	–	﹤0.01%	380
2025 Q2	$6.59K	Sell	272 -15,000	-98%	-$350K	﹤0.01%	355
2025 Q1	$387K	Buy	15,272 +14,780	+3,004%	+$387K	0.13%	86
2024 Q4	$13.1K	Sell	492 -3,821	-89%	-$104K	﹤0.01%	287
2024 Q3	$125K	Buy	4,313 +2,970	+221%	+$86.6K	0.04%	181
2024 Q2	$37.6K	Sell	1,343 -9,109	-87%	-$251K	0.01%	268
2024 Q1	$290K	Buy	10,452 +10,180	+3,743%	+$282K	0.1%	126
2023 Q4	$7.83K	Hold	272	–	–	﹤0.01%	490
2023 Q3	$9.02K	Sell	272 -317	-54%	-$11.2K	﹤0.01%	595
2023 Q2	$21.6K	Hold	589	–	–	0.01%	227
2023 Q1	$24K	Sell	589 -470	-44%	-$20.3K	0.01%	210
2022 Q4	$54.3K	Hold	1,059	–	–	0.03%	146
2022 Q3	$46K	Sell	1,059 -483	-31%	-$23.5K	0.03%	150
2022 Q2	$81K	Hold	1,542	–	–	0.06%	112
2022 Q1	$80K	Buy	1,542 +470	+44%	+$24.4K	0.06%	120
2021 Q4	$63K	Buy	+1,072	New	+$53.1K	0.05%	124

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Operose Advisors's PFE Position: Q2 2026 in Review

Operose Advisors reduced its Pfizer (PFE) stake by 0.05% in Q2 2026, selling an estimated $314 and leaving 25,400 shares worth $612K. The position accounts for 0.12% of the portfolio, ranked #88.

Operose Advisors first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $714K in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Operose Advisors held 25,400 shares of Pfizer worth $612K as of Q2 2026.
Operose Advisors sold 12 Pfizer shares in Q2 2026, an estimated $314.
Pfizer made up 0.12% of Operose Advisors's portfolio in Q2 2026, its #88 holding.
Operose Advisors first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
Operose Advisors's Pfizer position peaked at $714K in Q1 2026.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Operose Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.